Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 78: 990-996, 1995;
8750-7587/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khimenko, P. L.
Right arrow Articles by Taylor, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khimenko, P. L.
Right arrow Articles by Taylor, A. E.

Journal of Applied Physiology, Vol 78, Issue 3 990-996, Copyright © 1995 by American Physiological Society


ARTICLES

Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors

P. L. Khimenko, T. M. Moore, L. W. Hill, P. S. Wilson, S. Coleman, A. Rizzo and A. E. Taylor
Department of Physiology, College of Medicine, University of South Alabama, Mobile 36688, USA.

To evaluate the adenosine systems ability to reverse the endothelial damage produced by ischemia and reperfusion (I/R), we studied several different selective adenosine-receptor agonists and antagonists, a protein kinase A inhibitor, and a beta-adrenoreceptor antagonist in isolated buffer-perfused rat lungs. I/R (45 min/105 min) produced a sixfold increase in endothelial permeability as measured by the capillary filtration coefficient. Both a selective A2-receptor agonist (CGS-21680, 300 nM) and a beta-receptor agonist (isoproterenol, 10 microM) reversed the increased microvascular permeability. A nonselective adenosine-receptor antagonist (SPT, 20 microM) and a selective A1-receptor antagonist (DPCPX, 10 nM) had no effect on increased microvascular permeability. Also, isoproterenol and CGS-21680 reversed the damage being introduced after a selective A1-receptor agonist (CCPA, 100 nM). The nonspecific adenosine A1- and A2-receptor agonist NECA (12 nM) appeared to desensitize the A2 receptors and a protein kinase A inhibitor, adenosine-3',5'-cyclic monophosphothioate (Rp-cAMPS, 100 microM), blocked the reversal of endothelial damage by isoproterenol or A2-receptor agonist. Propranolol (100 microM) blocked the effect of isoproterenol but not the effect of CGS-21680. From this study we conclude that A2-receptor activation reverses endothelial damage associated with I/R by a mechanism independent of beta-receptors or Gi protein. However, a protein kinase A-3',5',-cyclic adenosine monophosphate pathway is activated by both the adenosine systems and beta-receptor activation.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. T. Lee, M. Kim, J. D. Joo, G. Gallos, J.-F. Chen, and C. W. Emala
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R959 - R969.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Parker
Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury
J Appl Physiol, December 1, 2000; 89(6): 2241 - 2248.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Harada, K. Okajima, K. Murakami, S. Usune, C. Sato, K. Ohshima, and T. Katsuragi
Adenosine and Selective A2A Receptor Agonists Reduce Ischemia/Reperfusion Injury of Rat Liver Mainly by Inhibiting Leukocyte Activation
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1034 - 1042.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Okusa, J. Linden, T. Macdonald, and L. Huang
Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney
Am J Physiol Renal Physiol, September 1, 1999; 277(3): F404 - F412.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. M. Moore, P. M. Chetham, J. J. Kelly, and T. Stevens
Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP
Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L203 - L222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Xavier-Neto, A. C. Pereira, A. H. Motoyama, and J. E. Krieger
A luciferase-engineered cell line for study of cAMP regulation in endothelial cells
Am J Physiol Cell Physiol, July 1, 1998; 275(1): C75 - C81.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Parker, C. L. Ivey, and J. A. Tucker
Gadolinium prevents high airway pressure-induced permeability increases in isolated rat lungs
J Appl Physiol, April 1, 1998; 84(4): 1113 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Parker and C. L. Ivey
Isoproterenol attenuates high vascular pressure-induced permeability increases in isolated rat lungs
J Appl Physiol, December 1, 1997; 83(6): 1962 - 1967.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. C. Robson, E. Kaczmarek, J. B. Siegel, D. Candinas, K. Koziak, M. Millan, W. W. Hancock, and F. H. Bach
Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation
J. Exp. Med., January 1, 1997; 185(1): 153 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online